ASG Pharma Invest SRL
ASG Pharma Invest reported total assets of €2.49m at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Mar 2026).
By total assets for 2025, ASG Pharma Invest ranks among the 1,000 largest of the 3,778 companies in its sector (NACE 7010) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of ASG Pharma Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ASG Pharma Invest's annual accounts
| 2025 | |
|---|---|
| Net result | −33,784 € |
| Equity | −13,784 € |
| Cash | 12,109 € |
| EBITDA | 73,035 € |
| Total assets | €2.49m |
Filed annual accounts
- Year ended 30 Sep 2025filed on 11 Mar 2026
ASG Pharma Invest's financial analysis
- Solvency-0.6%sector median: 53.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ASG Pharma Invest
ASG Pharma Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1012.783.235
- VAT number
- BE1012783235
- Peppol
- Registered · 0208:1012783235 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Aug 2024
- Registered office
- 8900 Ypres
- Latest accounts
- 2025 · filed on 11 Mar 2026
- Activity
- Activities of head offices (NACE 70100)
ASG Pharma Invest (SRL) has been based in Ypres since 2024, active in: activities of head offices. For 2025, it reports a net loss of 33,784 € and equity of −13,784 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ASG Pharma Invest
Companies in the same business, of comparable size and area, outside its group.
- Ponic Activities of head offices Doische · balance sheet €2.47m
- Promidea Activities of head offices Zonnebeke · balance sheet €2.66m
- Willems - van Huffel Activities of head offices Ghent · balance sheet €2.30m
- Desmeka Activities of head offices Mechelen · balance sheet €2.26m
- Dubotech Activities of head offices Roeselare · balance sheet €2.25m
- Cimmo Activities of head offices Bertem · balance sheet €2.13m
- BSK Management & Service Activities of head offices Büllingen · balance sheet €1.99m
- VB Management Activities of head offices Roeselare · balance sheet €1.96m
Frequently asked questions about ASG Pharma Invest
What is the revenue of ASG Pharma Invest?
ASG Pharma Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ASG Pharma Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE1012783235 for ASG Pharma Invest, if the company is VAT-registered. Its company number (CBE) is 1012.783.235.
Where is the registered office of ASG Pharma Invest?
According to the CBE register, the registered office of ASG Pharma Invest is in 8900 Ypres.
What is the equity of ASG Pharma Invest?
At the close of the 2025 financial year, the equity of ASG Pharma Invest amounts to -13,784 €, a solvency of -0.6% of total assets.
Who manages ASG Pharma Invest?
The register lists 2 active mandates at ASG Pharma Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is ASG Pharma Invest within its sector?
By total assets for 2025, ASG Pharma Invest ranks among the 1,000 largest of the 3,778 companies in its sector (NACE 7010) in Belgium that filed accounts for that financial year.
The full file of ASG Pharma Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →